6 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... and Secondary End ... Points #EBM #Neuro ... #IM #Fremanezumab ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... and Secondary End ... Points #EBM #Neuro ... #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Fremanezumab for ... to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
Nonvertebral Fracture #EBM ... #PrimaryCare #Endo ... #IM #Romosozumab ... #Alendronate #NEJM
The Death of MONA in ACS: Part IV – Aspirin provides protection against cardiovascular events (reinfarction,
stroke) as well as reduce ... cause mortality #EBM ... #EM #IM #Cardiology ... ASPIRIN #ISIS2 #RebelEM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
of the primary end ... warfarin (Panel A) #EBM ... #Cardiology #IM ... #REDUAL #Dabigatran ... AtrialFibrillation #NEJM